Share on StockTwits

CryoLife (NYSE:CRY) CEO Steven G. Anderson sold 30,523 shares of CryoLife stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $9.00, for a total value of $274,707.00. Following the completion of the transaction, the chief executive officer now directly owns 1,385,810 shares of the company’s stock, valued at approximately $12,472,290. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Shares of CryoLife (NYSE:CRY) traded down 2.47% on Wednesday, hitting $8.67. The stock had a trading volume of 106,154 shares. CryoLife has a 1-year low of $5.88 and a 1-year high of $12.14. The stock has a 50-day moving average of $9.56 and a 200-day moving average of $10.07. The company has a market cap of $243.5 million and a P/E ratio of 16.84.

CryoLife (NYSE:CRY) last issued its quarterly earnings data on Tuesday, April 29th. The company reported $0.04 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.07 by $0.03. The company had revenue of $35.73 million for the quarter, compared to the consensus estimate of $37.30 million. During the same quarter last year, the company posted $0.08 earnings per share. CryoLife’s revenue was up .6% compared to the same quarter last year. On average, analysts predict that CryoLife will post $0.20 earnings per share for the current fiscal year.

Several analysts have recently commented on the stock. Analysts at Zacks upgraded shares of CryoLife from an “underperform” rating to a “neutral” rating in a research note on Tuesday, April 29th. They now have a $9.90 price target on the stock.

CryoLife, Inc (NYSE:CRY) is a biological medical device company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.